Express News | Corrected-Sinopharm Tech Holdings FY23 (Not FY24) Revenue HKD 42.8 Million

ReutersJul 18 10:30 ET

Express News | Sinopharm Tech Holdings FY Revenue HKD 42.8 Million

ReutersJul 18 10:03 ET

Sinopharm Tech (08156.HK) proposes to restructure its share capital.

Sinopharm Tech (08156.HK) announced on June 14 that the board of directors has proposed to implement (i) share capital reduction, which involves canceling and paying up the share capital (limited to HKD 0.3 per share) to reduce the par value of each issued share from HKD 0.3125 to HKD 0.0125 so that the issued shares with a par value of HKD 0.0125 per share in the company's share capital will become a new share; and (ii) after the share capital reduction takes effect, the total proceeds generated from the share capital reduction will be used to offset the company's accumulated losses. Following the effectiveness of the share capital reduction, the statutory but unissued shares per share will

Gelonghui FinanceJun 14 10:59 ET

Express News | Sinopharm Tech - to Allot and Issue 300 Mln Integrated Asset Management (Asia) Shares at HK$0.1 per Share

ReutersJun 14 10:51 ET

Express News | Sinopharm Tech - Proposes to Implement Capital Reduction Involving Reduction of Par Value of Each Issued Share From HK$0.3125 to HK$0.0125

ReutersJun 14 10:50 ET

Express News | Sinopharm Tech Holdings Ltd - Proposed Capital Reorganisation

ReutersJun 14 10:49 ET